Abstract
Eales’ disease is an idiopathic primary vasculitis that involves the peripheral retinal veins. It usually affects young adults and results in recurrent vitreous hemorrhage. The condition has three distinct and often overlapping clinical stages, the inflammatory stage that principally manifests as perivascular sheathing, the neovascular stage that results in the formation of retinal new vessels and the vitreous hemorrhage stage due to bleeding from the new vessels. Though first described in the mid nineteenth century, the precise etiology of the disease is still unknown. Tuberculosis is often implicated directly or indirectly without undisputable histological or biochemical evidence. Many retinal vascular diseases resemble Eales’ retinopathy, and it is a diagnosis of exclusion. With the availability of specific tests for many conditions that cause vasculitis, one could now ascribe a specific etiology to many cases hitherto labelled as Eales’ disease. It is possible that the etiology of a large proportion of retinal vasculitis could be identified in future. An animal model of primary vasculitis could provide insight into the underlying pathology and help to refine treatment strategy and/or design methods to minimize recurrences and consequent retinal damage. Meanwhile, patients with Eales’ disease would continue to be treated with oral corticosteroid in the inflammatory stage, with retinal laser in the proliferative stage and with vitreoretinal surgery in the vitreous hemorrhage stage. The treatment outcomes are usually good.
References
Eales H. Retinal haemorrhages associated with epistaxis and constipation. Brim Med Rev. 1980;9:262.
Eales H. Primary retinal haemorrhage in young men. Ophthalmic Rev. 1882;1:41.
Wardsworth OF. Recurrent retinal haemorrhage followed by the development of blood vessels in the vitreous. Ophthalmic Rev. 1887;6:288–99.
Das T, Biswas J, Kumar A, et al. Eales’ disease. Indian J Ophthalmol. 1994;42:3–18.
Puttamma ST. Varied fundus picture of central retinal vasculitis. Tras Asia Pacific Acad Ophthalmol. 1970;3:520.
Duke-Elder S, Dobree JH. System of ophthalmology. Vol X. Diseases of the retina. London: Henry Kimpton; 1967.
Murthy KR, Abraham C, Baig SM, Badrinath SS. Eales’ disease. Proc All lnd Ophthalmol Soc. 1977;33:323.
Abraham C, Baig SM, Badrinath SS. Eales’ disease. Proc All India Ophthalmol Soc. 1977;33:226.
Stock W. Retinal haemorrhage due to miliary tuberculosis. Klin Monatsbl Augenh. 1937;99:367.
Gilbert TW. Periphlebitis and endovasculitis of retinal vessels. Klin M Monalsol Augeuh. 1935;94:335.
Biswas J, Therese L, Madhavan HN. Use of polymerase chain reaction in detection of Mycobacterium tuberculosis complex DNA from vitreous sample of Eales’ disease. Br J Ophthalmol. 1999;83(8):994.
Madhavan HN, Therese KL, Gunisha P, Jayanthi U, Biswas J. Polymerase chain reaction for detection of Mycobacterium tuberculosis in epiretinal membrane in Eales’ disease. Invest Ophthalmol Vis Sci. 2000;41(3):822–5.
Verma A, Biswas J, Dhanurekha L, Gayathri R, Therese KL. Detection of Mycobacterium tuberculosis with nested polymerase chain reaction analysis in enucleated eye ball in Eales’ disease. Int Ophthalmol. 2016;36(3):413–7.
Awasthi P, Mehrotra ML, Srivastava SN. Ocular conditions in pulmonary tuberculosis patients in India. Acta XX Concilium Ophthalmologicum. 1966;1025
Elliot A. Recurrent intraocular haemorrhage in young adults (Eales’ disease). A report of 31 cases. Trans Am Ophthalmic Soc. 1954;52:811.
Donders PC. Eales’ disease. Doc Ophthalmol. 1958;12:1–105.
Ashton N. Pathogenesis and aetiology of Eales’ disease. Acta XIX Concilium Ophtlmlmologicum. 1962:2–28.
Muthukkaruppan VR, Rengarajan K, Chakkalath HR, Namperumalsamy P. Immunological status of patients of Eales’ disease. Indian J Med Res. 1989;90:351.
Raj N, Krishnamurthy MS, Anantharaman DS. Prevalence of non-specific sensitivity in some parts of India. Indian J Med Res. 1975;63:1098.
Biswas J, Rao NA. Epiretinal membrane in Eales’ disease and other vascular retinopathies. Invest Ophllmlmol Vis Sci. 1990;31(Suppl):369.
Badrinath SS, Biswas J, Sharma T, Rao N. Immunophenotyping of inflammatory infiltrates in epiretinal (ERM) and subretinal membrane (SRM) in Eales’ disease. Invest Ophthalmol Vis Sci. 1992;33(Suppl):33.
Kalsi R, Patnaik B. The developing features of phlebitis retinae (a vertical study). Indian J Ophthalmol. 1979;27:87.
Charmis J. On the classification and management of the evolutionary course of Eales’ disease. Trans Ophthalmol Soc UK. 1965;5:157.
Biswas J, Sharma T, Gopal L, Madhavan HN, Sulochana KN, Ramakrishnan S. Eales disease-an update. Surv Ophthalmol. 2002;47:197–214.
Das T, Namperumalsamy P. Combined photocoagulation and cryotherapy in treatment of Eales’ retinopathy. Proc All Ind Ophthalmol Soc. 1987;45:108.
Biswas J, Pal B, Gondhale HP, Kharel R. Long-term outcomes of a large cohort of patients with Eales’ disease. Ocular immunolol Inflam. 2018;26:870–6.
Majji AB, Vemuganti GK, Shah VA, Singh S, Das T, Jalali S. A comparative study of epiretinal membranes associated with Eales’ disease: a clinicopathological evaluation. Eye. 2006;20:46–54.
Pratap VB, Mehra MK, Gupta RK. Electrophoretic pattern of serum proteins in Eales’ disease. Indian J Ophthalmol. 1976;23:14–16
Rengarajan K, Muthukakaruppan VR, Namperumalsamy P. Biochemical analysis of serum proteins from Eales’ patients. Curr Eye Res. 1989;8:1259.
Perentes Y, Chan CC, Bovey E, Uffer S, Herbort CP. Massive vascular endothelial growth factor (VEGF) expression in Eales’ disease. Klin Monasbl Augenheilkd. 2002;219:311–4.
Angayarkanni N, Swlvi R, Pukhraj R, Biswas J, Bhavesh SJ, Tink JT. Ratio of the vitreaous vascualr endothelial growth factor and pigment epithelial- derived factor in Eales’ disease. J Ocul Bio Dis Inform. 2009;2:20–8.
Pathengay A, Pilli S, Das T. Intravitreal triamcinolone acetonide in Eales’ disease: a case report. Eye. 2005;19:711–3.
Ishaq M, Feroze AH, Shahid M, Baig MA, Ameen SS, Feroze SH, et al. Intravitreal steroids may facilitate treatment of Eales’ disease (idiopathic retinal vasculitis): an interventional case series. Eye. 2007;21:1403–5.
Spaide R, Fisher Y. Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage. Retina. 2006;26:275–8.
Chanana B, Azad RV, Patwardhan S. Role of intravitreal bevacizumab in the management of Eales’ disease. Int Ophthalmol. 2010;30:57–61.
Moon SW, Song Y, Cho HY, lee BR, Sohn JH, park YS. The effect of intravitreal bevacizumab injdctin in Eales’ disese. J Korean Ophthalmol Soc. 2009;50:1595–9.
Patwardhan SD, Azad R, Shah BM, Sharma Y. Role of intravitreal bevacizumab in Eales disease with dense vitreous hemorrhage: a prospective randomized control study. Retina. 2011;31:866–70.
Gopal L, Abraham C. Efficacy of photocoagulation in Eales’ disease. Trans Asia-Pacific Acad. 1985;10:689.
Das T, Namperumalsamy P. Photocoagulation in Eales’ disease. Results of prospective randomised clinical study. Presented in XXVI Int Cong Ophthalmol, Singapore, 1990.
Namperumalsamy P, Kelkar AR, Das TP. Vitreous surgery in Eales’ disease-when and why. Presented in XXVI Ophthalmol, Singapore, 1990.
Badrinath SS, Honnatti MR. Vitrectomy in Eales’ disease. Acta Int Cong Ophthalmol. 1982;24:536.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this entry
Cite this entry
Das, T., Biswas, J., Tyagi, M. (2021). Eales’ Disease. In: Albert, D., Miller, J., Azar, D., Young, L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-90495-5_33-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-90495-5_33-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90495-5
Online ISBN: 978-3-319-90495-5
eBook Packages: Springer Reference MedicineReference Module Medicine